We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0–2.9; B.1.351: 3.6, 95% CI: 2.1–6.2; P.1: 2.6, 95% CI: 1.4–4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4–3.5; P.1: 2.2, 95% CI: 1.7–2.8).
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, Europe, variants of concern, Surveillance, 【초록키워드】 intensive care, B.1.351, variant, SARS-CoV-2 variant, P.1, hospitalisation, Admission, COVID-19 cases, adjusted odds ratio, 95% CI, 95% confidence interval, COVID-19 case, European, gene target, Seven, reported, significantly higher, 【제목키워드】 B.1.1.7, Seven,
【저자키워드】 COVID-19, SARS-CoV-2, Europe, variants of concern, Surveillance, 【초록키워드】 intensive care, B.1.351, variant, SARS-CoV-2 variant, P.1, hospitalisation, Admission, COVID-19 cases, adjusted odds ratio, 95% CI, 95% confidence interval, COVID-19 case, European, gene target, Seven, reported, significantly higher, 【제목키워드】 B.1.1.7, Seven,
우리는 SARS-CoV-2 변이 B.1.1.7/S 유전자 표적 실패(SGTF) 19,207건, B.1.351 436건 및 P.1 352건을 유럽 7개국에서 보고된 비변이 사례와 비교했습니다. 이러한 변이가 있는 COVID-19 사례는 입원에 대한 조정 승산비가 상당히 더 높았습니다(B.1.1.7/SGTF: 1.7, 95% 신뢰 구간(CI): 1.0–2.9; B.1.351: 3.6, 95% CI: 2.1– 6.2, P.1: 2.6, 95% CI: 1.4–4.8) 및 B.1.1.7/SGTF 및 P.1 중환자실 입원 사례(B.1.1.7/SGTF: 2.3, 95% CI: 1.4) –3.5, P.1: 2.2, 95% CI: 1.7–2.8).